October 24, 2016
Genotype 5 is the least common hepatitis C subtype, comprising less than 1% of global infections. Nonetheless, it is the most common type of infection in Southern Africa, where it represents more than half of all infections.
Although fewer clinical studies have been conducted with patients who have genotype 5 infection, current guidelines suggest that genotype 5 patients with or without liver damage should start treatment with sofosbuvir/ledipasvir or sofosbuvir/velpatasvir.
Credit: naruedom for iStock via Thinkstock.
Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today|
|PrEP Prescriptions Rise Sharply, but Unequally, in New York City|
|DACA, Immigrant Rights and the 'Larger Compassion' of the HIV Community|
|Let's Advance the Conversation Among Black Women on HIV and PrEP|
|Conversations With Federal HIV Leaders From the 2017 U.S. Conference on AIDS|
|Free Your (and Carl's) Mind: An Open Letter to Anthony Fauci About HIV Prevention Research Priorities|